
The fish insulin/insulin-like progress issue (IGF) pathway has weak management over carbohydrate metabolism. To know the molecular foundation for the metabolic variety, we characterised the forkhead field transcription issue O1A (FoxO1A), a downstream goal of the insulin/IGF pathway, in torafugu Takifugu rubripes. The cloned torafugu FoxO1A cDNA contained all conserved options crucial for its transcriptional exercise and a singular unspliced intron encoding a poly-glutamine stretch. Torafugu FoxO1A confirmed the IGF-dependent nuclear exclusion and in vitro binding to the well-conserved FoxO1 binding website, DAF-16-binding ingredient (DBE), however did not bind to the insulin-responsive ingredient by which mammalian FoxO1 mediates insulin results.
The next in silico genomic screening offered a listing of 587 potential torafugu FoxO1A goal genes containing the DBE. Some carbohydrate metabolic genes regulated by FoxO1 in mammals weren’t included within the record. We additional recognized about 250 potential fish FoxO1 goal genes by integrating outcomes of the DBE screening towards fish metagenome that contained 262 species. Neuronal processes gave the impression to be the widespread main perform of fish FoxO1, though additional annotation of the potential goal genes is required. These outcomes present part of the molecular foundation underlying the weak affiliation between the insulin/IGF pathway and carbohydrate metabolism in fish. Strategies that allow the development of recombinant DNA molecules are important instruments for organic analysis and biotechnology. Golden Gate cloning is used for meeting of a number of DNA fragments in an outlined linear order in a recipient vector utilizing a one-pot meeting process. Golden Gate cloning relies on using a sort IIS restriction enzyme for digestion of the DNA fragments and vector.
As a result of restriction websites for the sort IIS enzyme used for meeting have to be current on the ends of the DNA fragments and vector however absent from all inside sequences, particular care have to be taken to arrange DNA fragments and the recipient vector with a construction appropriate for meeting by Golden Gate cloning. On this article, protocols are introduced for preparation of DNA fragments, modules, and vectors appropriate for Golden Gate meeting cloning. Extra protocols are introduced for meeting of outlined components in a transcription unit, in addition to the stitching collectively of a number of transcription items into multigene constructs by the modular cloning (MoClo) pipeline.
Golden Gate Cloning-Suitable DNA Replicon/2A-Mediated Polycistronic Vectors for Crops

Forkhead transcription factor O1 (FoxO1) in torafugu pufferfish Takifugu rubripes: Molecular cloning, in vitro DNA binding, and target gene screening in fish metagenome
World Vacationers: DNA Barcoding Unmasks the Origin of Cloning Asteroid Larvae from the Caribbean
Melanoma Marker(PNL2) Antibody |
|||
BNC810894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNCB0894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNCB0894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC550894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC550894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC430894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC430894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC470894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC470894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC880894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC880894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC940894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC940894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNCP0894-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(PNL2), PerCP conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC040894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC040894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC050894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC050894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL |
Anti-Melanoma Marker antibody |
|||
STJ16100745 | St John's Laboratory | 1 mL | EUR 352 |
Melanoma Marker(PNL2) Antibody |
|||
BNCR0894-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(PNL2), RPE conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNUB0894-100 | Biotium | 100uL | EUR 209 |
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNUB0894-500 | Biotium | 500uL | EUR 458 |
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC680894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC680894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC700894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC700894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC400894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF640R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC400894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF640R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC610894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC610894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC800894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), CF680 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNC800894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), CF680 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNCH0894-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNCH0894-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(PNL2) Antibody |
|||
BNUM0894-50 | Biotium | 50uL | EUR 395 |
Description: Primary antibody against Melanoma Marker(PNL2), 1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCA0895-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(KBA.62), APC conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCAP0895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCAP0895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC810895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF680R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC810895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF680R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCB0895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), Biotin conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCB0895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), Biotin conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC550895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF555 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC550895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF555 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC430895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF543 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC430895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF543 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC470895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF647 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC470895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF647 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC880895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF488A conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC880895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF488A conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC940895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF594 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC940895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF594 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCP0895-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(KBA.62), PerCP conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC040895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF405S conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC040895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF405S conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC050895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF405M conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC050895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF405M conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCR0895-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(KBA.62), RPE conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNUB0895-100 | Biotium | 100uL | EUR 209 |
Description: Primary antibody against Melanoma Marker(KBA.62), Concentration: 0.2mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNUB0895-500 | Biotium | 500uL | EUR 458 |
Description: Primary antibody against Melanoma Marker(KBA.62), Concentration: 0.2mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC680895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF568 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC680895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF568 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC700895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF770 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC700895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF770 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC400895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF640R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC400895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF640R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC610895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF660R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC610895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF660R conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC800895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF680 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNC800895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), CF680 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCH0895-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(KBA.62), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNCH0895-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(KBA.62), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(KBA.62) Antibody |
|||
BNUM0895-50 | Biotium | 50uL | EUR 395 |
Description: Primary antibody against Melanoma Marker(KBA.62), 1mg/mL |
Anti-Tyrosinase (Melanoma Marker) Monoclonal Antibody |
|||
M00326 | BosterBio | 100ug/vial | EUR 397 |
Description: Mouse Monoclonal Tyrosinase (Melanoma Marker) Antibody. Validated in IHC and tested in Human. |
Anti-SOX10 (Melanoma Marker) Monoclonal Antibody |
|||
M00758 | BosterBio | 100ug/vial | EUR 397 |
Description: Mouse Monoclonal SOX10 (Melanoma Marker) Antibody. Validated in IHC and tested in Human. |
Anti-S100A (Melanoma Marker) Monoclonal Antibody |
|||
M02503 | BosterBio | 100ug/vial | EUR 397 |
Description: Mouse Monoclonal S100A (Melanoma Marker) Antibody. Validated in IHC and tested in Human. |
S100A (Melanoma Marker) (S1/61) Antibody |
|||
BNC941695-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against S100A (Melanoma Marker) (S1/61),CF594 conjugate, Concentration: 0.1mg/mL |
S100A (Melanoma Marker) (S1/61) Antibody |
|||
BNC941695-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against S100A (Melanoma Marker) (S1/61),CF594 conjugate, Concentration: 0.1mg/mL |
Tyrosinase (Melanoma Marker) (TYR/2024R) Antibody |
|||
BNC942024-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against Tyrosinase (Melanoma Marker) (TYR/2024R), CF594 conjugate, Concentration: 0.1mg/mL |
Tyrosinase (Melanoma Marker) (TYR/2024R) Antibody |
|||
BNC942024-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against Tyrosinase (Melanoma Marker) (TYR/2024R), CF594 conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (SOX10/2311R) Antibody |
|||
BNC942311-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against SOX10 (Melanoma Marker) (SOX10/2311R), CF594 conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (SOX10/2311R) Antibody |
|||
BNC942311-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against SOX10 (Melanoma Marker) (SOX10/2311R), CF594 conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (rSOX10/1074) Antibody |
|||
BNC942312-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against SOX10 (Melanoma Marker) (rSOX10/1074), CF594 conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (rSOX10/1074) Antibody |
|||
BNC942312-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against SOX10 (Melanoma Marker) (rSOX10/1074), CF594 conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(HMB45 + A103 + T311) Antibody |
|||
BNCA0702-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(HMB45 + A103 + T311), APC conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(DT101+ BC199 + HMB45) Antibody |
|||
BNCA0703-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Melanoma Marker(DT101+ BC199 + HMB45), APC conjugate, Concentration: 0.1mg/mL |
S100A (Melanoma Marker) (S1/61) Antibody |
|||
BNCA1695-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against S100A (Melanoma Marker) (S1/61),APC conjugate, Concentration: 0.1mg/mL |
Tyrosinase (Melanoma Marker) (TYR/2024R) Antibody |
|||
BNCA2024-250 | Biotium | 250uL | EUR 394 |
Description: Primary antibody against Tyrosinase (Melanoma Marker) (TYR/2024R), APC conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (SOX10/2311R) Antibody |
|||
BNCA2311-250 | Biotium | 250uL | EUR 394 |
Description: Primary antibody against SOX10 (Melanoma Marker) (SOX10/2311R), APC conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (rSOX10/1074) Antibody |
|||
BNCA2312-250 | Biotium | 250uL | EUR 394 |
Description: Primary antibody against SOX10 (Melanoma Marker) (rSOX10/1074), APC conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(HMB45 + A103 + T311) Antibody |
|||
BNCAP0702-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(HMB45 + A103 + T311), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(HMB45 + A103 + T311) Antibody |
|||
BNCAP0702-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(HMB45 + A103 + T311), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(DT101+ BC199 + HMB45) Antibody |
|||
BNCAP0703-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Melanoma Marker(DT101+ BC199 + HMB45), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Melanoma Marker(DT101+ BC199 + HMB45) Antibody |
|||
BNCAP0703-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Melanoma Marker(DT101+ BC199 + HMB45), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (SOX10/2311R) Antibody |
|||
BNC802311-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against SOX10 (Melanoma Marker) (SOX10/2311R), CF680 conjugate, Concentration: 0.1mg/mL |
SOX10 (Melanoma Marker) (SOX10/2311R) Antibody |
|||
BNC802311-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against SOX10 (Melanoma Marker) (SOX10/2311R), CF680 conjugate, Concentration: 0.1mg/mL |